← Back to list

Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C

MSCI ACWI IMI Genomic Innovation Select Screened 100

Equities Sustainable (ESG)
ISIN
IE000KD0BZ68
Issuer
Xtrackers
TER
0.30%
Latest closing price
N/A
Fund Size
€10 m As of: Sep 30, 2026
Domicile
Ireland
Distribution Policy
Accumulating
Replication Method
Physical
Base Currency
USD
WKN / Ticker
DBX0R2 / XGEN

Data availability

Data is available for 2 of 5 areas for this fund.

  • Master data (TER, index, size): As of: Sep 30, 2026
  • Closing price: not available
  • Price history (at least 20 prices): not available
  • Holdings: As of: Jul 29, 2026
  • Risk figures: not available

Missing information is marked as “not available” and is not estimated. The issuer’s documents are authoritative.

At a glance

Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (ISIN IE000KD0BZ68) is a fund from Xtrackers (fund type: ETF). Benchmark index: MSCI ACWI IMI Genomic Innovation Select Screened 100. Its ongoing charges (TER) are 0.30% per year. The fund size is €10 m. Distribution policy: Accumulating. Replication: Physical. Fund domicile: Ireland.

Key Facts
  • Launch date 12.07.2022 (4 years)
  • Number of Holdings 100
  • Strategy Passive (index tracking)
  • Base Currency USD
  • Currency hedging No
  • Distribution Policy Accumulating
  • Replication Method Physical
  • Securities lending Yes
  • Domicile IE
  • UCITS Compliant Yes

Price development

Error loading comparison.
There is not enough price data available for this period yet.

Pure price change based on stored closing prices; distributions, purchase costs and taxes are not included. Different currencies and index types (price or total return index) can distort the comparison line. Past performance is not a reliable indicator of future results.

Risk figures (12 months)

No calculated risk figures are available for this fund yet.

The official summary risk indicator (SRI, scale 1–7) is in the issuer’s key information document (KID). The figures here are historical values and do not replace it.

Documents

We have no documents stored for this fund. The key information document (KID), factsheet and prospectus are provided by the issuer.

Search documents at Xtrackers

Tracking difference and tracking error

We have no comparison series stored for this fund’s index, so a tracking analysis is not possible.

What does the fund invest in?
As of 29.07.2026 · Source: justETF / etfdb
Sector Breakdown
  • Health care 99.7%
  • Other 0.3%
Country Breakdown
  • United States 67.8%
  • Switzerland 11.5%
  • China 8.6%
  • Netherlands 6.0%
  • United Kingdom 4.5%
  • Spain 0.4%
  • Sweden 0.3%
  • Australia 0.2%
  • Japan 0.2%
  • Italy 0.1%
  • All others 0.2%

Holdings

Showing 10 holdings that together make up 43.3 % of fund assets. (out of 100 holdings in total).

# Name ISIN Sector Country Weight
1 Illumina, Inc. US4523271090 – – 5.18 %
2 Natera US6323071042 – – 4.90 %
3 Agilent Technologies US00846U1016 – – 4.84 %
4 Danaher Corp. US2358511028 – – 4.53 %
5 Vertex Pharmaceuticals US92532F1003 – – 4.30 %
6 Lonza Group AG CH0013841017 – – 4.22 %
7 GSK PLC ADR US37733W2044 – – 4.00 %
8 Roche Holding AG CH1499059983 – – 3.94 %
9 Moderna US60770K1079 – – 3.76 %
10 argenx US04016X1019 – – 3.64 %
Cost calculator
What does this ETF cost you per year – and over your whole investment horizon?
Cost in year 1
–
Total cost impact
–

Simplified model based on the TER, excluding order fees, spreads, taxes and tracking difference. Not investment advice.

Alternatives on the same index
Other ETFs tracking the MSCI ACWI IMI Genomic Innovation Select Screened 100 – cheapest first.
We know of no other ETFs tracking exactly this index.

Frequently asked questions about the Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C

The total expense ratio (TER) of the Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C is 0.30% per year. The costs are deducted from the fund assets on an ongoing basis and are already reflected in its performance.

The Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C tracks the MSCI ACWI IMI Genomic Innovation Select Screened 100. Our index encyclopedia explains the index and lists all funds that track it.

The Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C is accumulating: income such as dividends is not paid out but automatically reinvested in the fund.

The Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C uses physical replication: it holds the securities of the index directly – either in full or as a representative sample (sampling).

The fund size of the Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C is €10 m. A large fund size usually indicates good tradability and a lower risk of the fund being closed.

The Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C is domiciled in Ireland. The fund domicile affects, among other things, how withholding taxes are treated inside the fund.

The provider (issuer) of the Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C is Xtrackers.

All information without guarantee. It is provided for information purposes only and does not constitute investment advice.